- Enhanced capability allows UPS Healthcare to produce 1,200 lbs. of dry ice per hour in the U.S. and Canada.
- UPS Healthcare is collaborating with Stirling Ultracold to supply portable freezers for storage of vaccines at a range of -20°C to -80°
- Services are in response to complex, urgent demands for approved COVID-19 vaccine storage and distribution efforts when the time comes.
UPS today announced service enhancements to aid in the massive distribution efforts for COVID-19 vaccines in the coming months. As part of these enhancements, UPS Healthcare now can produce up to 1,200 lbs. of dry ice per hour in its U.S. facilities to support the storage and transportation of cold chain products, such as frozen vaccines, in accordance with manufacturer storage requirements. The increased production also allows UPS to make dry ice available for U.S. and Canadian hospitals, clinics and other points of care requiring dry ice to store vaccines locally. Dry ice will be sourced at UPS Worldport® and can be available next day.
A major spike in demand is causing logistics providers to plan for what some analysts fear may be a dry ice shortage, as pharmaceutical companies strategize getting hundreds of millions of their vaccine doses safely to communities around the U.S. and internationally.
“Enhancing our dry ice production capabilities increases our supply chain agility and reliability immensely when it comes to handling complex vaccines for our customers,” says Wes Wheeler, president of UPS Healthcare. “Healthcare facilities in Louisville, Dallas and Ontario will ensure we have the capability to produce dry ice to sufficiently pack and replenish shipments as needed to keep products viable and effective.”
In addition to dry ice production, UPS will also launch, in collaboration with Stirling Ultracold, a joint effort to provide portable ultra-low temperature (ULT) freezers. These portable freezers will be distributed and used in smaller point of care facilities requiring a more permanent solution for longer term freezer storage. UPS will be working with Stirling to offer the Stirling ULT25 and Undercounter Model SU105 to thermally protect critical vaccines requiring ultra-low temperatures ranging anywhere from -20°C to -80°C.
“We are truly proud to partner with UPS in this critical effort. As the leading manufacturer of small and portable ULT devices, Stirling Ultracold freezers integrate well with UPS Healthcare logistics to provide complete cold-chain of custody for COVID-19 vaccines from the drug manufacturers to medical facilities,” says Dusty Tenney, CEO of Stirling. “This program will help ensure vaccines remain effective next year, and for years to come, as future vaccines and biologics are developed to keep the world healthy and safe.”
